Amanote Research
Register
Sign In
Establishment and Characterization of the Gemcitabine‑resistant Human Pancreatic Cancer Cell Line SW1990/gemcitabine
Oncology Letters
- Greece
doi 10.3892/ol.2019.10627
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
July 17, 2019
Authors
Yue Yu
Fei Ding
Meng Gao
Yi Jia
Le Ren
Publisher
Spandidos Publications
Related search
Aspirin Inhibits Proliferation of Gemcitabine-Resistant Human Pancreatic Cancer Cells and Augments Gemcitabine-Induced Cytotoxicity
Acta Pharmacologica Sinica
Medicine
Pharmacology
Galunisertib Plus Gemcitabine vs. Gemcitabine for First-Line Treatment of Patients With Unresectable Pancreatic Cancer
British Journal of Cancer
Cancer Research
Oncology
Inhibitory Effect of Baicalein Combined With Gemcitabine in Human Pancreatic Cancer Cell Lines
Oncology Letters
Cancer Research
Oncology
Cyclopentenyl Cytosine Increases Gemcitabine Radiosensitisation in Human Pancreatic Cancer Cells
British Journal of Cancer
Cancer Research
Oncology
Establishment of a Human Pancreatic Cancer Cell Line and Detection of Pancreatic Cancer Associated Antigen.
Tohoku Journal of Experimental Medicine
Biochemistry
Medicine
Genetics
Molecular Biology
Clove (Syzygium Aromaticum) Extract Potentiates Gemcitabine Cytotoxic Effect on Human Cervical Cancer Cell Line
International Journal of Cancer Research
Cancer Research
Oncology
Qingyihuaji Formula Reverses Gemcitabine Resistant Human Pancreatic Cancer Through Regulate LncRNA AB209630/miR-373/EphB2-NANOG Signals
Bioscience Reports
Biochemistry
Cell Biology
Molecular Biology
Biophysics
Gemcitabine Combined With Capecitabine Compared to Gemcitabine With or Without Erlotinib as First-Line Chemotherapy in Patients With Advanced Pancreatic Cancer
Cancer Research and Treatment
Cancer Research
Oncology
Outcomes of Gemcitabine Treatment for Invasive Ductal Pancreatic Cancer
Suizo
